The Center for Pediatric Transplant and Advanced Kidney and Urologic Diseases at the Phyllis and David Komansky Center for Children’s Health offers a new integrated approach to treating children and adolescents suffering from kidney and urologic diseases, including those who may need a kidney transplant. Urologic disease and kidney disease are the two primary events that result in kidney failure and require a child having a kidney transplant. Our pediatric nephrologists and urologists offer expertise in the diagnosis and treatment of rare and progressive conditions that can lead to end-stage renal disease in children, as well as kidney and bladder malformations in infants and toddlers. They provide comprehensive medical and surgical care for patients – from newborns to young adults – with outcomes ranked among the nation’s best.
The Center for Pediatric Transplant and Advanced Kidney and Urologic Diseases draws on the expertise and resources of the NewYork-Presbyterian/Weill Cornell Transplant Program – the first kidney transplant program established in New York State. The Transplant Program has performed over 3,000 kidney transplants; more than 200 kidney transplants are performed each year. Since 2006, NewYork-Presbyterian/Weill Cornell has had one of the highest volume transplant programs in the country, made possible through advances such as kidney swaps and blood-type incompatible procedures that have revolutionized live organ donor transplantations. The kidney transplant program offers the latest transplant management protocols and surgical interventions with lower rejection rates and higher graft survival rates as compared to national outcomes.
In 2008, the transplant team at NewYork-Presbyterian/Weill Cornell and The Rogosin Institute successfully performed one of the nation’s first never-ending altruistic donor (NEAD) “chain” renal transplants. The successful triple transplant procedure was coordinated by Sandip Kapur, MD, Chief of Transplant Surgery and Director of Kidney and Pancreas Transplant programs at NewYork-Presbyterian/Weill Cornell. The innovative NEAD approach may forever change the way transplants are performed in the United States.
The dedicated team of physicians and surgeons in the Transplant Program is responsible for many significant advances made over the past several decades in transplant surgery and the maintenance of healthy organs. They have been at the forefront of developing and improving:
For the first time in the history of kidney transplantation, physicians are able to individualize the medication regimen used to suppress the immune system and reduce the amount of exposure to these medications by utilizing molecular tools developed at NewYork-Presbyterian/Weill Cornell.